Targeted elimination of breast cancer cells with low proteasome activity is sufficient for tumor regression

Breast Cancer Research and Treatment

Volumn 141, Issue 2, 2013, Pages 197-203

  Vlashi, Erina ^a   Lagadec, Chann ^a   Chan, Mabel ^a   Frohnen, Patricia ^a   McDonald, Alexandra Jean ^a   Pajonk, Frank ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Breast cancer stem cells; Mammospheres; Proteasome; Thymidine kinase; Xenografts

Indexed keywords

HYBRID PROTEIN; PROTEASOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER REGRESSION; CANCER STEM CELL; CELL RENEWAL; CELL SHAPE; CELL STRAIN MCF 7; CELL STRAIN MDA MB 231; CELL STRAIN T47D; DOWN REGULATION; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; TUMOR CELL LINE;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; DOWN-REGULATION; ENZYME ACTIVATION; FEMALE; HETEROGRAFTS; HUMANS; MICE; NEOPLASTIC STEM CELLS; PROTEASOME ENDOPEPTIDASE COMPLEX; SPHEROIDS, CELLULAR; TUMOR BURDEN; TUMOR CELLS, CULTURED;

EID: 84885323839     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-013-2688-6     Document Type: Article

References (14)

1. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100:3983-3988
2. Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG, Liu S et al (2007) ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1(5):555-567
3. Phillips TM, McBride WH, Pajonk F (2006) The response of CD24(-/low)/CD44 + breast cancer-initiating cells to radiation. J Natl Cancer Inst 98(24):1777-1785
4. Woodward WA, Chen MS, Behbod F, Alfaro MP, Buchholz TA, Rosen JM (2007) WNT/beta-catenin mediates radiation resistance of mouse mammary progenitor cells. Proc Natl Acad Sci U S A 104(2):618-623
5. Lagadec C, Dekmezian C, Bauche L, Pajonk F (2012) Oxygen levels do not determine radiation survival of breast cancer stem cells. PLoS One 7(3):e34545
6. Karimi-Busheri F, Rasouli-Nia A, Mackey JR, Weinfeld M (2010) Senescence evasion by MCF-7 human breast tumor-initiating cells. Breast Cancer Res 12(3):R31
7. Lagadec C, Vlashi E, Della Donna L, Dekmezian C, Pajonk F (2012) Radiation-induced reprogramming of breast cancer cells. Stem Cells 30(5):833-844
8. Lagadec C, Vlashi E, Della Donna L, Meng Y, Dekmezian C, Kim K, Pajonk F (2010) Survival and self-renewing capacity of breast cancer initiating cells during fractionated radiation treatment. Breast Cancer Res 12(1):R13
9. Vlashi E, Kim K, Lagadec C, Donna LD, McDonald JT, Eghbali M, Sayre JW, Stefani E, McBride W, Pajonk F (2009) In vivo imaging, tracking, and targeting of cancer stem cells. J Natl Cancer Inst 101(5):350-359
10. Hoyt MA, Zhang M, Coffino P (2005) Probing the ubiquitin/proteasome system with ornithine decarboxylase, a ubiquitin-independent substrate. Methods Enzymol 398:399-413
11. Glas R, Bogyo M, McMaster JS, Gaczynska M, Ploegh HL (1998) A proteolytic system that compensates for loss of proteasome function. Nature 392(6676):618-622
12. Reya T, Morrison SJ, Clarke MF, Weissman IL (2001) Stem cells, cancer, and cancer stem cells. Nature 414(6859):105-111
13. Charafe-Jauffret E, Ginestier C, Iovino F, Tarpin C, Diebel M, Esterni B, Houvenaeghel G, Extra JM, Bertucci F, Jacquemier J et al (2010) Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer. Clin Cancer Res 16(1):45-55
14. Elfadl D, Hodgkinson VC, Long ED, Scaife L, Drew PJ, Lind MJ, Cawkwell L (2011) A pilot study to investigate the role of the 26S proteasome in radiotherapy resistance and loco-regional recurrence following breast conserving therapy for early breast cancer. Breast 20(4):334-337